Quantcast

Latest autoimmune diseases Stories

2014-05-01 12:32:03

- Consistent effects seen across key MRI measures of disease activity; Effects were sustained beyond two-year pivotal MS studies - - Approximately 80 percent of patients treated with Lemtrada did not receive a third course of treatment in the first year of the extension - CAMBRIDGE, MA, May 1, 2014 /CNW/ - Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced new magnetic resonance imaging (MRI) data from the Lemtrada (alemtuzumab) clinical development program. In Lemtrada...

2014-05-01 12:31:32

Sephure® ensures proper placement of suppositories, improves patient quality of life and compliance CONCORD, Mass., May 1, 2014 /PRNewswire/ -- Jennifer Davagian Ensign, Founder & CEO of Cristcot Inc. today announced that Sephure®, a first-of-its-kind disposable suppository applicator, is now available to the millions of people who require suppository medication therapy. Although billions of suppositories are sold around the world each year, there is no standard of care for...

2014-05-01 10:03:33

Three new mango studies presented at 2014 Experimental Biology Conference Three new mango-related studies were presented this week at the 2014 Federation of American Societies for Experimental Biology (FASEB) in San Diego, revealing initial findings on the effects of mango consumption on ulcerative colitis and bone parameters in animal models. "The mango industry's nutrition research program is committed to advancing our understanding of the role mangos can play as part of a healthy...

2014-05-01 08:37:31

- Initiation of Phase 1/2a clinical trial in subjects with dry eye disease expected mid-2014 DURHAM, N.C., May 1, 2014 /PRNewswire/ -- Parion Sciences, a company dedicated to the development of novel treatments for ocular and pulmonary diseases, announced today that it has received acceptance from the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for P-321 Ophthalmic Solution for the treatment of dry eye disease. Preclinical data that...

2014-05-01 08:36:19

May is Lupus Awareness Month; Lupus Foundation of America Education Programs and Events Taking Place Nationwide WASHINGTON, May 1, 2014 /PRNewswire-USNewswire/ -- In recognition of Lupus Awareness Month this May, the Lupus Foundation of America is calling on the public to take action and raise their voice to increase lupus awareness and help solve the cruel mystery that is lupus. Lupus is a mysterious and devastating disease that ravages different parts of the body and has no known cause and...

2014-04-30 16:30:12

Afternoon to Honor Robbyn Sockolow, MD; Hosted by Veteran TV News Anchor Liz Cho and featuring a Fashion Presentation by Bergdorf Goodman NEW YORK, April 30, 2014 /PRNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA), Greater New York Chapter, will host their Twenty-First Annual Women of Distinction Luncheon at the Waldorf-Astoria on Thursday, May 1(st). The luncheon will be hosted by veteran WABC-TV News Anchor, Liz Cho. To purchase tickets to the 21(st) Annual...

2014-04-30 12:30:11

Expert Opinion Indicates That Humira and Cimzia Have the Best Clinical Profiles of Key Marketed Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., April 30, 2014 /PRNewswire/ --Decision Resources Group finds that, when asked to select the top three most persuasive end points when prescribing a new drug for psoriatic arthritis (PsA), the highest percentages of surveyed United States and European rheumatologists selected the American College of Rheumatology (ACR)...

2014-04-30 10:21:24

May provide therapeutic target for treating inflammatory bowel disease and preventing colitis-associated colorectal cancer, according to new research published in the American Journal of Pathology The adhesion molecule CD146 plays a vital role in inflammation and offers a promising therapeutic target for treating inflammatory bowel disease (IBD) as well as preventing colitis-associated colorectal cancer, say scientists. Targeting CD146 with anti-CD146 antibody AA98, especially in...

2014-04-28 23:03:54

According to a new report from BCC Research, the global market for drugs to treat systemic lupus erythematosus (SLE), is expected to grow to $2.6 billion by 2018, with a five-year compound annual growth rate (CAGR) of 22.4%. The North American market, the fastest growing regional segment overall, is growing at a tremendous 24.7% CAGR. Wellesley, Mass., (PRWEB) April 28, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, DRUGS FOR TREATING SYSTEMIC LUPUS...

2014-04-28 16:27:23

Project Runway's Tim Gunn Joins 400 NYC Leaders at S.L.E. Lupus Foundation's Annual Bag Ladies Luncheon NEW YORK, April 28, 2014 /PRNewswire/ -- Hundreds of leaders in New York's fashion, entertainment, travel, philanthropic and lupus communities turned out to support the fight against lupus at the S.L.E. Lupus Foundation's sixth annual New York Bag Ladies Luncheon. Raising over $350,000, the sold-out event featured Emmy-winning Project Runway host Tim Gunn as Master of Ceremonies....


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related